IPO registrations (S-1, F-1) · Registrants
TC BioPharm (Holdings) plc
- SEC CIK
- 1872812 · filings on EDGAR ↗
- Former names
- TC BioPharm (Holdings) Ltd (2021–2021)
- Registration
- Form F-1, first filed 2021-10-26, last 2024-08-23; 7 initial registrations, 12 amendments
- Outcome
- Final prospectus filed 2022-02-14; declared effective 2022-02-10
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- X0
- Business address
- MAXIM 1, 2 PARKLANDS WAY, Holytown, X0 ML1 4WR
- EDGAR entity type
- operating
- Insiders and CEO pay
- TC BioPharm (Holdings) plc on the corporate pages
Offering terms
- Final price
- $4.25 per ADS (424B4 filed 2022-02-14, an initial public offering)
- Shares sold
- 4,117,648
- Gross proceeds
- $17,500,004 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol TCBP
- Lead underwriters
- The Benchmark Company; EF Hutton
- Syndicate
- of Contents; of Civil Liabilities
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: TC BioPharm (Holdings) plc EXACT (CIK (EXACT))
- SEC filer: TC BioPharm (Holdings) plc EXACT (CIK (EXACT))
Filings 39
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-10-26 | F-1 | F-1 (foreign registration) | TC BioPharm (Holdings) Ltd | 0001493152-21-026271 ↗ |
| 2021-10-27 | F-1/A | F-1/A (amendment) | TC BioPharm (Holdings) Ltd | 0001493152-21-026504 ↗ |
| 2021-12-23 | F-1/A | F-1/A (amendment) | TC BioPharm (Holdings) Ltd | 0001493152-21-032421 ↗ |
| 2022-01-14 | F-1/A | F-1/A (amendment) | TC BioPharm (Holdings) plc | 0001493152-22-001326 ↗ |
| 2022-01-21 | F-1/A | F-1/A (amendment) | TC BioPharm (Holdings) plc | 0001493152-22-001983 ↗ |
| 2022-01-31 | F-1/A | F-1/A (amendment) | TC BioPharm (Holdings) plc | 0001493152-22-002741 ↗ |
| 2022-02-09 | F-1/A | F-1/A (amendment) | TC BioPharm (Holdings) plc | 0001493152-22-003620 ↗ |
| 2022-02-10 | F-1MEF | F-1MEF (added securities) | TC BioPharm (Holdings) plc | 0001493152-22-003862 ↗ |
| 2022-02-10 | EFFECT | EFFECT (declared effective) | TC BioPharm (Holdings) plc | 9999999995-22-000393 ↗ |
| 2022-02-14 | 424B4 | 424B4 (final prospectus) | TC BioPharm (Holdings) plc | 0001493152-22-004536 ↗ |
| 2022-02-14 | 424B4 | 424B4 (final prospectus) | TC BioPharm (Holdings) plc | 0001493152-22-004541 ↗ |
| 2022-03-02 | 424B4 | 424B4 (final prospectus) | TC BioPharm (Holdings) plc | 0001493152-22-005807 ↗ |
| 2022-05-24 | F-1 | F-1 (foreign registration) | TC BioPharm (Holdings) plc | 0001493152-22-014832 ↗ |
| 2022-05-31 | F-1/A | F-1/A (amendment) | TC BioPharm (Holdings) plc | 0001493152-22-015490 ↗ |
| 2022-06-02 | EFFECT | EFFECT (declared effective) | TC BioPharm (Holdings) plc | 9999999995-22-001676 ↗ |
| 2022-06-03 | 424B1 | 424B1 (final prospectus) | TC BioPharm (Holdings) plc | 0001493152-22-015803 ↗ |
| 2022-12-12 | F-1 | F-1 (foreign registration) | TC BioPharm (Holdings) plc | 0001493152-22-035163 ↗ |
| 2022-12-23 | EFFECT | EFFECT (declared effective) | TC BioPharm (Holdings) plc | 9999999995-22-003636 ↗ |
| 2023-03-23 | F-1 | F-1 (foreign registration) | TC BioPharm (Holdings) plc | 0001493152-23-008734 ↗ |
| 2023-03-27 | F-1/A | F-1/A (amendment) | TC BioPharm (Holdings) plc | 0001493152-23-009155 ↗ |
| 2023-03-27 | EFFECT | EFFECT (declared effective) | TC BioPharm (Holdings) plc | 9999999995-23-000685 ↗ |
| 2023-03-29 | 424B4 | 424B4 (final prospectus) | TC BioPharm (Holdings) plc | 0001493152-23-009510 ↗ |
| 2023-08-28 | F-1 | F-1 (foreign registration) | TC BioPharm (Holdings) plc | 0001493152-23-030392 ↗ |
| 2023-11-06 | EFFECT | EFFECT (declared effective) | TC BioPharm (Holdings) plc | 9999999995-23-003227 ↗ |
| 2023-12-13 | F-1/A | F-1/A (amendment) | TC BioPharm (Holdings) plc | 0001493152-23-044632 ↗ |
| 2023-12-14 | F-1/A | F-1/A (amendment) | TC BioPharm (Holdings) plc | 0001493152-23-044922 ↗ |
| 2023-12-18 | EFFECT | EFFECT (declared effective) | TC BioPharm (Holdings) plc | 9999999995-23-003672 ↗ |
| 2023-12-21 | 424B4 | 424B4 (final prospectus) | TC BioPharm (Holdings) plc | 0001493152-23-045635 ↗ |
| 2024-06-24 | EFFECT | EFFECT (declared effective) | TC BioPharm (Holdings) plc | 9999999995-24-001928 ↗ |
| 2024-07-02 | F-1 | F-1 (foreign registration) | TC BioPharm (Holdings) plc | 0001493152-24-026004 ↗ |
| 2024-08-09 | F-1/A | F-1/A (amendment) | TC BioPharm (Holdings) plc | 0001493152-24-030881 ↗ |
| 2024-08-12 | EFFECT | EFFECT (declared effective) | TC BioPharm (Holdings) plc | 9999999995-24-002500 ↗ |
| 2024-08-14 | 424B4 | 424B4 (final prospectus) | TC BioPharm (Holdings) plc | 0001493152-24-031860 ↗ |
| 2024-08-16 | F-1 | F-1 (foreign registration) | TC BioPharm (Holdings) plc | 0001493152-24-032827 ↗ |
| 2024-08-23 | F-1/A | F-1/A (amendment) | TC BioPharm (Holdings) plc | 0001493152-24-033780 ↗ |
| 2024-08-28 | F-1MEF | F-1MEF (added securities) | TC BioPharm (Holdings) plc | 0001493152-24-034233 ↗ |
| 2024-08-28 | EFFECT | EFFECT (declared effective) | TC BioPharm (Holdings) plc | 9999999995-24-002669 ↗ |
| 2024-08-29 | 424B4 | 424B4 (final prospectus) | TC BioPharm (Holdings) plc | 0001493152-24-034421 ↗ |
| 2024-12-11 | EFFECT | EFFECT (declared effective) | TC BioPharm (Holdings) plc | 9999999995-24-003745 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-09 | F-1/A | registration statement | $4.25 | 3,764,706 | $16,000,000 | Nasdaq TCBP | 4 | primary document; price line, shares headline, proceeds computed, cover names 4 | document ↗ | |
| 2022-02-14 | 424B4 | final prospectus | $4.25 | 4,117,648 | $17,500,004 | Nasdaq TCBP | 4 | primary document; price line, shares headline, proceeds computed, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Renaissance Capital Partners Ltd | TenPercentOwner | 2 | 2022–2023 | ||
| Randall Kenneth Edward | TenPercentOwner | 4 | 2022–2023 | ||
| Randall Diana Elizabeth | TenPercentOwner | 2 | 2022–2023 | ||
| Randall Mark Edward | TenPercentOwner | 2 | 2023 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2022-12-13 | TC BioPharm (Holdings) plc | Biotechnology | $7,350,000 | $7,350,000 | 2 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | TC BioPharm (Holdings) plc | Form D private offerings | CIK (EXACT) | |
| SEC filer | TC BioPharm (Holdings) plc | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), X0 first:
- Abcam plc X0
- Immunocore Holdings plc X0
- Autolus Therapeutics plc X0
- Orchard Therapeutics plc X0
- Freeline Therapeutics Holdings plc X0
- Achilles Therapeutics plc X0
- Gyroscope Therapeutics Holdings plc X0
- OKYO Pharma Ltd X0
- Exscientia plc X0
- BioNTech SE 2M
In other datasets, the same topic (Health) in X0:
- Form D issuer: Abcam plc (Form D private offerings)
Interests: Biological Products, (No Diagnostic Substances) · Health